<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
	<predicate lemma="generate">
		<roleset id="generate.01" name="" wordnet="1">
			<roles>
				<role n="0" descr="agent, causer		//gene, process//
"/>
				<role n="1" descr="thing created		
"/>
			</roles>
			<example src="MEDLINE" no="1">
				<text>
Prnd generates major transcripts of 1.7 and 2.7 kb as well as some unusual chimeric transcripts generated by intergenic splicing with Prnp.

</text>
				<arg n="0">Prnd		
</arg>
				<arg n="1">major transcripts of 1.7 and 2.7 kb  
</arg>
				<fdg>
         1	Prnd	prnd	subj:&gt;2	@SUBJ %NH &lt;?&gt; N NOM SG
         2	generates	generate	main:&gt;0	@+FMAINV %VA V PRES SG3
         3	major	major	attr:&gt;4	@A&gt; %&gt;N A ABS
         4	transcripts	transcript	obj:&gt;2	@OBJ %NH N NOM PL
         5	of	of	mod:&gt;4	@&lt;NOM-OF %N&lt; PREP
         6	1.7	1.7	pcomp:&gt;5	@&lt;P %NH NUM CARD
         7	and	and	cc:&gt;6	@CC %CC CC
         8	2.7	2.7	attr:&gt;9	@A&gt; %&gt;N NUM CARD
         9	kb	kb	cc:&gt;6	@&lt;P %NH ABBR NOM SG
         10	as well as	as well as	cc:&gt;9	@CC %CC CC
         11	some	some	det:&gt;14	@DN&gt; %&gt;N DET
         12	unusual	unusual	attr:&gt;13	@A&gt; %&gt;N A ABS
         13	chimeric	chimeric	attr:&gt;14	@A&gt; %&gt;N A ABS
         14	transcripts	transcript	cc:&gt;9	@&lt;P %NH N NOM PL
         15	generated	generate	mod:&gt;14	@-FMAINV %VP EN
         16	by	by	ha:&gt;15	@ADVL %EH PREP
         17	intergenic	intergenic	attr:&gt;18	@A&gt; %&gt;N &lt;?&gt; A ABS
         18	splicing	splicing	pcomp:&gt;16	@&lt;P %NH N NOM SG
         19	with	with	com:&gt;15	@ADVL %EH PREP
         20	Prnp	prnp	pcomp:&gt;19	@&lt;P %NH &lt;?&gt; N NOM SG
         21	.     .
</fdg>
			</example>
			<example src="MEDLINE" no="2">
				<text>
Prnd generates major transcripts of 1.7 and 2.7 kb as well as some unusual chimeric transcripts generated by intergenic splicing with Prnp.

</text>
				<arg n="0">[by] intergenic splicing with Prnp	
</arg>
				<arg n="1">some unusual chimeric transcripts
</arg>
				<fdg>
         1	Prnd	prnd	subj:&gt;2	@SUBJ %NH &lt;?&gt; N NOM SG
         2	generates	generate	main:&gt;0	@+FMAINV %VA V PRES SG3
         3	major	major	attr:&gt;4	@A&gt; %&gt;N A ABS
         4	transcripts	transcript	obj:&gt;2	@OBJ %NH N NOM PL
         5	of	of	mod:&gt;4	@&lt;NOM-OF %N&lt; PREP
         6	1.7	1.7	pcomp:&gt;5	@&lt;P %NH NUM CARD
         7	and	and	cc:&gt;6	@CC %CC CC
         8	2.7	2.7	attr:&gt;9	@A&gt; %&gt;N NUM CARD
         9	kb	kb	cc:&gt;6	@&lt;P %NH ABBR NOM SG
         10	as well as	as well as	cc:&gt;9	@CC %CC CC
         11	some	some	det:&gt;14	@DN&gt; %&gt;N DET
         12	unusual	unusual	attr:&gt;13	@A&gt; %&gt;N A ABS
         13	chimeric	chimeric	attr:&gt;14	@A&gt; %&gt;N A ABS
         14	transcripts	transcript	cc:&gt;9	@&lt;P %NH N NOM PL
         15	generated	generate	mod:&gt;14	@-FMAINV %VP EN
         16	by	by	ha:&gt;15	@ADVL %EH PREP
         17	intergenic	intergenic	attr:&gt;18	@A&gt; %&gt;N &lt;?&gt; A ABS
         18	splicing	splicing	pcomp:&gt;16	@&lt;P %NH N NOM SG
         19	with	with	com:&gt;15	@ADVL %EH PREP
         20	Prnp	prnp	pcomp:&gt;19	@&lt;P %NH &lt;?&gt; N NOM SG
         21	.     .
</fdg>
			</example>
			<example src="MEDLINE" no="3">
				<text>
A transcription start site is located approximately 4 kilobases 5 to the translation codon, and an RNA splice of 3863 bases occurs in the 5-untranslated region to generate mature HeLa cell mRNA.

</text>
				<arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region
</arg>
				<arg n="1">mature HeLa cell mRNA
</arg>
				<fdg>
         1	A	a	det:&gt;4	@DN&gt; %&gt;N DET SG
         2	transcription	transcription	attr:&gt;3	@A&gt; %&gt;N N NOM SG
         3	start	start	attr:&gt;4	@A&gt; %&gt;N N NOM SG
         4	site	site	subj:&gt;5	@SUBJ %NH N NOM SG
         5	is	be	v-ch:&gt;6	@+FAUXV %AUX V PRES SG3
         6	located	locate		@-FMAINV %VP EN
         7	approximately	approximately	ad:&gt;8	@AD-A&gt; %E&gt; ADV
         8	4	4	qn:&gt;9	@QN&gt; %&gt;N NUM CARD
         9	kilobases	kilobas*	obj:&gt;6	@OBJ %NH &lt;?&gt; N NOM PL
         10	5	5	mod:&gt;9	@&lt;NOM %N&lt; NUM CARD
         11	&apos;	&apos;
         12	to	to		@ADVL %EH PREP
         13	the	the	det:&gt;16	@DN&gt; %&gt;N DET
         14	translation	translation	attr:&gt;15	@A&gt; %&gt;N N NOM SG
         15	initiation	initiation	attr:&gt;16	@A&gt; %&gt;N N NOM SG
         16	codon	codon	pcomp:&gt;12	@&lt;P %NH N NOM SG
         17	,	,
         18	and	and	cc:&gt;6	@CC %CC CC
         19	an	an	det:&gt;21	@DN&gt; %&gt;N DET SG
         20	RNA	rna	attr:&gt;21	@A&gt; %&gt;N ABBR NOM SG
         21	splice	splice	subj:&gt;25	@SUBJ %NH N NOM SG
         22	of	of	mod:&gt;21	@&lt;NOM-OF %N&lt; PREP
         23	3863	3863	qn:&gt;24	@QN&gt; %&gt;N NUM CARD
         24	bases	basis	pcomp:&gt;22	@&lt;P %NH N NOM PL
         25	occurs	occur	cc:&gt;6	@+FMAINV %VA V PRES SG3
         26	in	in	ha:&gt;25	@ADVL %EH PREP
         27	the	the	det:&gt;32	@DN&gt; %&gt;N DET
         28	5	5	qn:&gt;32	@QN&gt; %&gt;N NUM CARD
         29	&apos;	&apos;
         30	-	-
         31	untranslated	untranslated	attr:&gt;32	@A&gt; %&gt;N A ABS
         32	region	region	pcomp:&gt;26	@&lt;P %NH N NOM SG
         33	to	to	pm:&gt;34	@INFMARK&gt; %AUX INFMARK&gt;
         34	generate	generate	mod:&gt;32	@-FMAINV %VA V INF
         35	mature	mature	attr:&gt;36	@A&gt; %&gt;N A ABS
         36	HeLa	hela	attr:&gt;37	@A&gt; %&gt;N N NOM SG
         37	cell	cell	attr:&gt;38	@A&gt; %&gt;N N NOM SG
         38	mRNA.	mrna.	attr:&gt;39	@A&gt; %&gt;N ABBR NOM SG
</fdg>
			</example>
			<example src="MEDLINE" no="4">
				<text>
The TBC method was optimized to generate sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.

</text>
				<arg n="0">The TBC method </arg>
				<arg n="1">sequential overlapping fragments</arg>
				<fdg>  
	1	The	the	det:&gt;3	@DN&gt; %&gt;N DET
	2	TBC	tbc	attr:&gt;3	@A&gt; %&gt;N ABBR NOM SG
	3	method	method	subj:&gt;4	@SUBJ %NH N NOM SG
	4	was	be	v-ch:&gt;5	@+FAUXV %AUX V PAST
	5	optimized	optimize		@-FMAINV %VP EN
	6	to	to	pm:&gt;7	@INFMARK&gt; %AUX INFMARK&gt;
	7	generate	generate	cnt:&gt;5	@-FMAINV %VA V INF
	8	sequential	sequential	obj:&gt;7	@OBJ %NH A ABS
	9	overlapping	overlapping	subj:&gt;10	@SUBJ %NH A ABS
	10	fragments	fragment		@+FMAINV %VA V PRES SG3
	11	(	(
	12	approximately	approximately	ad:&gt;13	@AD-A&gt; %E&gt; ADV
	13	0.4-	0.4-	qn:&gt;14	@QN&gt; %&gt;N NUM CARD
	14	0.5	0.5	attr:&gt;15	@A&gt; %&gt;N NUM CARD
	15	kb	kb		@APP %NH ABBR NOM SG	@A&gt; %&gt;N ABBR NOM SG	@NH %NH ABBR NOM SG
	16	)	)
	17	for	for		@CS %CS CS	@ADVL %EH PREP
	18	each	each		@SUBJ %NH PRON SG	@OBJ %NH PRON SG	@&lt;P %NH PRON SG	@&lt;NOM %N&lt; PRON SG	@ADVL %EH PRON SG
	19	of	of	mod:&gt;18	@&lt;NOM-OF %N&lt; PREP
	20	the	the	det:&gt;22	@DN&gt; %&gt;N DET
	21	gene	gene	attr:&gt;22	@A&gt; %&gt;N N NOM SG
	22	sequences	sequence	pcomp:&gt;19	@&lt;P %NH N NOM PL
	23	,	,
	24	and	and		@CC %CC CC
	25	simultaneous	simultaneous	cc:&gt;27	@A&gt; %&gt;N A ABS
	26	and	and	cc:&gt;27	@CC %CC CC
	27	sequential	sequential	attr:&gt;28	@A&gt; %&gt;N A ABS
	28	combinations	combination		@NH %NH N NOM PL	@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@APP %NH N NOM PL	@&lt;P %NH N NOM PL
	29	of	of	mod:&gt;28	@&lt;NOM-OF %N&lt; PREP
	30	overlapping	overlap	pcomp:&gt;29	@&lt;P-FMAINV %VA ING
	31	fragments	fragment	obj:&gt;30	@OBJ %NH N NOM PL
	32	were	be	v-ch:&gt;33	@+FAUXV %AUX V PAST PL
	33	tested	test		@-FMAINV %VP EN
	34	for	for	ha:&gt;33	@ADVL %EH PREP
	35	their	they	attr:&gt;36	@A&gt; %&gt;N PRON PERS GEN PL3
	36	ability	ability	pcomp:&gt;34	@&lt;P %NH N NOM SG
	37	to	to	pm:&gt;38	@INFMARK&gt; %AUX INFMARK&gt;
	38	be	be	v-ch:&gt;39	@-FAUXV %AUX V INF
	39	assembled	assemble	mod:&gt;36	@-FMAINV %VP EN
	40	under	under	loc:&gt;39	@ADVL %EH PREP
	41	an	an	det:&gt;42	@DN&gt; %&gt;N DET SG
	42	array	array	pcomp:&gt;40	@&lt;P %NH N NOM SG
	43	of	of	mod:&gt;42	@&lt;NOM-OF %N&lt; PREP
	44	PCR	pcr	attr:&gt;45	@A&gt; %&gt;N ABBR NOM SG
	45	conditions	condition	pcomp:&gt;43	@&lt;P %NH N NOM PL
        46	.     .
</fdg>
			</example>
			<example src="MEDLINE" no="5">
				<text>
The bidentate RNase III Dicer cleaves microRNA precursors to generate the 21-23 nt long mature RNAs.

</text>
				<arg n="0">The bidentate RNase III Dicer </arg>
				<arg n="1">the 21-23 nt long mature RNAs</arg>
				
			</example>
			<example src="MEDLINE" no="6">
				<text>
In the absence of L-arginine, nNOS has been shown to generate superoxide (O(2)-).

</text>
				<arg n="0">nNOS </arg>
				<arg n="1">superoxide</arg>
				
			</example>
			<example src="MEDLINE" no="7">
				<text>
Human leukocyte antigen (HLA)-G molecules are generated by an alternative splicing of the primary transcript of the gene and display specialized function in regulating the immune response.

</text>
				<arg n="0">an alternative splicing of the primary transcript of the gene </arg>
				<arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
				
			</example>
			<example src="MEDLINE" no="8">
				<text>
Abeta peptides are generated from proteolysis of the amyloid precursor proteins (APP) by beta- and gamma-secretases.

</text>
				<arg n="0">proteolysis of the amyloid precursor proteins (APP) </arg>
				<arg n="1">Abeta peptides</arg>
			
			</example>
			<example src="EMBO" no="1">
				<text>
In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that degradation does not generate specific fragments or occurs rapidly precludes any definitive conclusions.

</text>
				<arg n="0">degradation</arg>
				<arg n="1">specific fragments</arg>
				<arg n="M-NEG">not</arg>
				</example>
				<example src="EMBO" no="2">
					<text>
The DNA-binding mutant (Stat5aEE-AA) of Stat5a was generated by mutating amino acids EE (437 and 438) to AA.FLAG epitope was added to the C-terminus of Stat5aEE-AA.

</text>
					<arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
					<arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
					
				</example>
				<example src="EMBO" no="3">
					<text>
To analyse specifically protein expression of FHL2 in human tissues we generated a monoclonal antibody against FHL2.

	</text>
					<arg n="0">we</arg>
					<arg n="1">a monoclonal antibody against FHL2</arg>
				</example>
				<example src="EMBO" no="4">
					<text>
Although no crystal structure of the AR is available to date, one might speculate that L723 in H3 is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating the correct three-dimensional interaction surface.

</text>
					<arg n="0">L723 in H3
</arg>
					<arg n="1">the correct three-dimensional interaction surface
</arg>
					<fdg>
1	Although	although	pm:&gt;8	@CS %CS CS
2	no	no	det:&gt;4	@DN&gt; %&gt;N DET
3	crystal	crystal	attr:&gt;4	@A&gt; %&gt;N N NOM SG
4	structure	structure	subj:&gt;8	@SUBJ %NH N NOM SG
5	of	of	mod:&gt;4	@&lt;NOM-OF %N&lt; PREP
6	the	the	det:&gt;7	@DN&gt; %&gt;N DET
7	AR	ar	pcomp:&gt;5	@&lt;P %NH N NOM SG
8	is	be	cnd:&gt;15	@+FMAINV %VA V PRES SG3
9	available	available	comp:&gt;8	@PCOMPL-S %NH A ABS
10	to	to	mod:&gt;9	@&lt;NOM %N&lt; PREP
11	date	date	pcomp:&gt;10	@&lt;P %NH N NOM SG
12	,	,
13	one	one	subj:&gt;14	@SUBJ %NH PRON NOM SG
14	might	might	v-ch:&gt;15	@+FAUXV %AUX V AUXMOD
15	speculate	speculate	main:&gt;0	@-FMAINV %VA V INF
16	that	that	pm:&gt;20	@CS %CS CS
17	L712	l712	subj:&gt;20	@SUBJ %NH N NOM SG
18	in	in	mod:&gt;17	@&lt;NOM %N&lt; PREP
19	H3	h3	pcomp:&gt;18	@&lt;P %NH N NOM SG
20	is	be		@+FMAINV %VA V PRES SG3
21	either	either	subj:&gt;23	@SUBJ %NH PRON NOM SG
22	directly	directly	man:&gt;23	@ADVL %EH ADV
23	involved	involve	comp:&gt;20	@+FMAINV %VA V PAST
24	in	in	phr:&gt;23	@ADVL %EH PREP
25	the	the	det:&gt;26	@DN&gt; %&gt;N DET
26	AR	ar	pcomp:&gt;24	@&lt;P %NH N NOM SG
27	-	-
28	FHL2	fhl2	attr:&gt;29	@A&gt; %&gt;N N NOM SG
29	interaction	interaction	obj:&gt;23	@OBJ %NH N NOM SG
30	or	or	cc:&gt;23	@CC %CC CC
31	,	,
32	alternatively	alternatively	meta:&gt;34	@ADVL %EH ADV
33	,	,
34	is	be	cc:&gt;23	@+FMAINV %VA V PRES SG3
35	essential	essential	comp:&gt;34	@PCOMPL-S %NH A ABS
36	for	for	mod:&gt;35	@&lt;NOM %N&lt; PREP
37	generating	generate	pcomp:&gt;36	@&lt;P-FMAINV %VA ING
38	the	the	det:&gt;42	@DN&gt; %&gt;N DET
39	correct	correct	attr:&gt;40	@A&gt; %&gt;N A ABS
40	three-dimensional	three-dimensional	attr:&gt;41	@A&gt; %&gt;N A ABS
41	interaction	interaction	attr:&gt;42	@A&gt; %&gt;N N NOM SG
42	surface	surface	obj:&gt;37	@OBJ %NH N NOM SG
43	.     .
</fdg>
				</example>
				<example src="EMBO" no="5">
					<text>
In addition, the AR N-terminus is required to generate a functional interaction surface, since its deletion abolishes FHL2 binding.

</text>
					<arg n="0">the AR N-terminus
</arg>
					<arg n="1">a functional interaction surface
</arg>
					<fdg>
1	In	in	cla:&gt;8	@ADVL %EH PREP
2	addition	addition	pcomp:&gt;1	@&lt;P %NH N NOM SG
3	,	,
4	the	the	det:&gt;6	@DN&gt; %&gt;N DET
5	AR	ar	attr:&gt;6	@A&gt; %&gt;N N NOM SG
6	N-terminus	n-terminus	subj:&gt;7	@SUBJ %NH N NOM SG
7	is	be	v-ch:&gt;8	@+FAUXV %AUX V PRES SG3
8	required	require	main:&gt;0	@-FMAINV %VP EN
9	to	to	pm:&gt;10	@INFMARK&gt; %AUX INFMARK&gt;
10	generate	generate	cnt:&gt;8	@-FMAINV %VA V INF
11	a	a	det:&gt;14	@DN&gt; %&gt;N DET SG
12	functional	functional	attr:&gt;13	@A&gt; %&gt;N A ABS
13	interaction	interaction	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	surface	surface	obj:&gt;10	@OBJ %NH N NOM SG
15	,	,
16	since	since	pm:&gt;19	@CS %CS CS
17	its	it	attr:&gt;18	@A&gt; %&gt;N PRON GEN SG3
18	deletion	deletion	subj:&gt;19	@SUBJ %NH N NOM SG
19	abolishes	abolish	tmp:&gt;10	@+FMAINV %VA V PRES SG3
20	FHL2	fhl2	obj:&gt;19	@OBJ %NH N NOM SG
21	binding	binding	copred:&gt;19	@OBJ %NH N NOM SG
22	.     .
</fdg>
				</example>
			</roleset>
		</predicate>
	</frameset>
